| |
|
|
|
Biocryst Pharma Inc  
|
|
10.22 -0.7 (-0.06%) |
03-05 10:47 |
|
Open: |
11.08 |
Pre close: |
10.92 |
Target:
|
13.05 
|
|
High: |
11.19 |
Low: |
10.05 |
Resistance:
|
11.17
12.90
|
|
Volume: |
2,340,233 |
Market Cap: |
1814M |
Support:
|
8.37
6.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.39
|
MACD |
MACD(12,26):
|
0.54 |
|
MA(20): |
10.69  |
Signal(12,26,9): |
0.64 |
|
MA(100): |
7.20 |
Stochastic Oscillator |
%K(14,3):
|
62.63 |
|
MA(250): |
5.22 |
%D(3): |
73.96 |
|
Average Volume(K) |
3-Month: |
739378
|
52-Week |
High:
|
12.90 |
|
10-Days: |
586151 |
Low: |
1.58 |
|
RSI |
RSI(14):
|
50.25 |
Change(%): |
232.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.800 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
176.57 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-57.4 |
Shares Float (M) |
153.41 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.85 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
243.8 |
% Held by Institutions |
73.95 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.353 |
Shares Short (K) |
30950 |
|
Book Value (p.s.) |
0.190 |
EBITDA (p.s.) |
-0.689 |
P/E |
-13.07 |
|
Sales Per Share |
0.303 |
Qtrly Earnings Growth |
0.00 |
P/BV |
55.05 |
|
Profit Margin |
-233.45 |
Operating Cash Flow
(M) |
-103.03 |
P/S |
34.51 |
|
Operating Margin |
-228.81 |
Levered Free Cash Flow
(M) |
-63.88 |
P/CF |
-17.93 |
|
|
|
|
|
|
